LeflunoMide EP IMpurity F Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Leflunomide EP Impurity F is an isomer of Leflunomide (L322755), which is an immunosuppressive antirheumatic drug.

LeflunoMide EP IMpurity F Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

LeflunoMide EP IMpurity F Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
Chemsigma International Co., Ltd.	+86-2558742998 +86-19951791336	info@chemsigma.com	China	1810	58
CR Corporation Limited	+8613062833949	fred.wen@crcorporation.cn	China	8645	58
sgtlifesciences pvt ltd	+8617013299288	dj@sgtlifesciences.com	China	12373	58
Moxin Chemicals	+86-17320513646 +8617320513646	anna@molcoo.com	China	10000	58
Sinco Pharmachem (ShenZhen) R&D Co., Ltd.	+undefined18603013401	jack.lin@sincopharmachem.com	China	10000	58
BOC Sciences	1-631-485-4226; 16314854226	info@bocsci.com	United States	9920	65
S.Z. PhyStandard Bio-Tech. Co., Ltd.	0755-83725681-603		China	4496	50
BOC Sciences	16314854226	info@bocsci.com	United States	9923	65
Tonichem Pharmaceutical Technology Co., Ltd.	+86 (0752) 222-7171, +86 15815821171		China	1120	58

1403564-06-6()Verwandte Suche:

---

• LeflunoMide EP IMpurity F
• Leflunomide ortho-Isomer
• Leflunomide Impurity 6(Leflunomide EP Impurity F)
• Leflunomide Impurity F
• 5-methyl-N-[2-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide
• Leflunomide EP Impurity F (Leflunomide-2-isomer)
• Leflunomide impurities1338
• Leflunomide otho-Isomer
• 5-Methyl-N-(2-(trifluoromethyl)phenyl)isoxazole-4-carboxamide (Leflunomide Impurity)
• 4-Isoxazolecarboxamide, 5-methyl-N-[2-(trifluoromethyl)phenyl]-
• Leflunomide EP Impurity F 5-methyl-N-(2-(trifluoromethyl)phenyl)isoxazole-4-carboxamide
• 5-Methyl-N-[2-(trifluoromethyl)phenyl]isoxazole-4-carboxamide
• Leflunomide EP Impurity F/Leflunomide ortho-Isomer/5-Methyl-N-[2-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide
• 1403564-06-6